Dystrophin expression somatic reversion prednisone-treated untreated Duchenne dystrophy CIDD Study Group mechanism prednisone muscle strength function Duchenne muscular dystrophy DMD unknown possibility clinical improvement prednisone-induced alterations skeletal muscle dystrophin muscle biopsies patients conclusion randomized double-blind trial prednisone dystrophin content Western blots antibody staining tissue sections studies significant differences dystrophin content treatment prednisone mg/kg/d prednisone mg/kg/d placebo groups interest presence numbers dystrophin-positive fibers revertants clusters antibody-stained tissue sections one-half Duchenne patients Mutation analysis revertants DMD patients identifiable deletions half Duchenne patients Mutation analysis revertants DMD patients identifiable deletions duplications nondeletion patients Prednisone treatment prevalence revertants Revertants likely due second-site mutation somatic cell restoration translational reading frame dystrophin transcript 